Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Neuroinflammation in Alzheimer’s Disease
Isaac G. Onyango, Gretsen Velezmoro Jáuregui, Mária Čarná, et al.
Biomedicines (2021) Vol. 9, Iss. 5, pp. 524-524
Open Access | Times Cited: 204

Showing 26-50 of 204 citing articles:

The Neuroprotective Effects and Therapeutic Potential of the Chalcone Cardamonin for Alzheimer’s Disease
Kimberly Barber, Patricia Mendonca, Karam F. A. Soliman
Brain Sciences (2023) Vol. 13, Iss. 1, pp. 145-145
Open Access | Times Cited: 27
Microglia and Astrocytes in Alzheimer’s Disease: Significance and Summary of Recent Advances
Qianting Deng, Chongyun Wu, Emily M. Parker, et al.
Aging and Disease (2023)
Open Access | Times Cited: 27
Diet’s Role in Modifying Risk of Alzheimer’s Disease: History and Present Understanding
William B. Grant, Steven M. Blake
Journal of Alzheimer s Disease (2023) Vol. 96, Iss. 4, pp. 1353-1382
Open Access | Times Cited: 25
Gut–Brain Axis and Neuroinflammation: The Role of Gut Permeability and the Kynurenine Pathway in Neurological Disorders
Rowan Kearns
Cellular and Molecular Neurobiology (2024) Vol. 44, Iss. 1
Open Access | Times Cited: 15
Potential use of antioxidants for the treatment of chronic inflammatory diseases
Alexander V. Blagov, Volha I. Summerhill, Vasily N. Sukhorukov, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 13
Neuroinflammation of Microglial Regulation in Alzheimer’s Disease: Therapeutic Approaches
Haiyun Chen, Yuhan Zeng, Dan Wang, et al.
Molecules (2024) Vol. 29, Iss. 7, pp. 1478-1478
Open Access | Times Cited: 11
Cellular junction dynamics and Alzheimer’s disease: a comprehensive review
Keyvan Asghari, Zahra Niknam, Shadi Mohammadpour-Asl, et al.
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access | Times Cited: 10
GLUT1-mediated microglial proinflammatory activation contributes to the development of stress-induced spatial learning and memory dysfunction in mice
Xue Wang, Yuhan Wu, Ying-Rui Tian, et al.
Cell & Bioscience (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 8
Flavonoids as Potential Therapeutics Against Neurodegenerative Disorders: Unlocking the Prospects
Md. Faysal, Zerrouki Dehbia, Mehrukh Zehravi, et al.
Neurochemical Research (2024) Vol. 49, Iss. 8, pp. 1926-1944
Closed Access | Times Cited: 8
Inflammaging and Brain Aging
Maria Carolina Jurcău, Anamaria Jurcău, Alexander Cristian, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 19, pp. 10535-10535
Open Access | Times Cited: 8
Exosomes and non-coding RNAs: bridging the gap in Alzheimer’s pathogenesis and therapeutics
Chunhui Guo, You Yanqiu, Jibing Chen, et al.
Metabolic Brain Disease (2025) Vol. 40, Iss. 1
Open Access | Times Cited: 1
Multi-target-directed therapeutic strategies for Alzheimer’s disease: controlling amyloid-β aggregation, metal ion homeostasis, and enzyme inhibition
Jeasang Yoo, Jimin Lee, Byeongha Ahn, et al.
Chemical Science (2025)
Open Access | Times Cited: 1
Ghrelin Induces Ferroptosis Resistance and M2 Polarization of Microglia to Alleviate Neuroinflammation and Cognitive Impairment in Alzheimer’s Disease
Yaoxue Guo, Junli Zhao, Yizhi Liu, et al.
Journal of Neuroimmune Pharmacology (2025) Vol. 20, Iss. 1
Closed Access | Times Cited: 1
Depletion of MGO or Its Derivatives Ameliorate CUMS-Induced Neuroinflammation
Bing Liu, Ke Dong, Yun Zhao, et al.
Cells (2025) Vol. 14, Iss. 6, pp. 397-397
Open Access | Times Cited: 1
The clock modulator Nobiletin mitigates astrogliosis‐associated neuroinflammation and disease hallmarks in an Alzheimer’s disease model
Marvin Wirianto, Chih‐Yen Wang, Eunju Kim, et al.
The FASEB Journal (2022) Vol. 36, Iss. 3
Open Access | Times Cited: 37
Roles of neuronal toll-like receptors in neuropathic pain and central nervous system injuries and diseases
Çiğdem Acıoğlu, Robert F. Heary, Stella Elkabes
Brain Behavior and Immunity (2022) Vol. 102, pp. 163-178
Open Access | Times Cited: 35
Molecular mechanisms in Alzheimer's disease and related potential treatments such as structural target convergence of antibodies and simple organic molecules
Nassima Oumata, Kui Lu, Yuou Teng, et al.
European Journal of Medicinal Chemistry (2022) Vol. 240, pp. 114578-114578
Closed Access | Times Cited: 29
Therapeutic Strategies in Huntington’s Disease: From Genetic Defect to Gene Therapy
Anamaria Jurcău, Maria Carolina Jurcău
Biomedicines (2022) Vol. 10, Iss. 8, pp. 1895-1895
Open Access | Times Cited: 28
Anticholinergic effect of resveratrol with vitamin E on scopolamine-induced Alzheimer’s disease in rats: Mechanistic approach to prevent inflammation
Ahmed I. Foudah, Sushma Devi, Aftab Alam, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 22
Implications of gut and oral microbiota in neuroinflammatory responses in Alzheimer's disease
Laura Bello-Corral, Lisa Alves-Gomes, Jesús Antonio Fernández-Fernández, et al.
Life Sciences (2023) Vol. 333, pp. 122132-122132
Open Access | Times Cited: 20
The central role of the NLRP3 inflammasome pathway in the pathogenesis of age-related diseases in the eye and the brain
Jack Jonathan Maran, Moradeke M. Adesina, Colin Green, et al.
Ageing Research Reviews (2023) Vol. 88, pp. 101954-101954
Closed Access | Times Cited: 18
Anti-Neuroinflammatory Potential of Natural Products in the Treatment of Alzheimer’s Disease
Mingzhenlong Deng, Wanli Yan, Zhicheng Gu, et al.
Molecules (2023) Vol. 28, Iss. 3, pp. 1486-1486
Open Access | Times Cited: 17
Implicative role of cytokines in neuroinflammation mediated AD and associated signaling pathways: Current progress in molecular signaling and therapeutics
Sneha Kumari, Rishika Dhapola, Prajjwal Sharma, et al.
Ageing Research Reviews (2023) Vol. 92, pp. 102098-102098
Closed Access | Times Cited: 16
Circular RNA aptamers ameliorate AD-relevant phenotypes by targeting PKR
Xin Feng, Bowen Jiang, Si-Nan Zhai, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 7
Exploring the Comprehensive Neuroprotective and Anticancer Potential of Afzelin
Mateusz Kciuk, Nitika Garg, Sanchit Dhankhar, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 6, pp. 701-701
Open Access | Times Cited: 6

Scroll to top